Wednesday, 28 December 2011

Phenolurn




Phenolurn may be available in the countries listed below.


Ingredient matches for Phenolurn



Tamoxifen

Tamoxifen citrate (a derivative of Tamoxifen) is reported as an ingredient of Phenolurn in the following countries:


  • Japan

International Drug Name Search

Monday, 26 December 2011

Analper FEM




Analper FEM may be available in the countries listed below.


Ingredient matches for Analper FEM



Ibuprofen

Ibuprofen is reported as an ingredient of Analper FEM in the following countries:


  • Venezuela

International Drug Name Search

Friday, 23 December 2011

Methylprednisolon




Methylprednisolon may be available in the countries listed below.


Ingredient matches for Methylprednisolon



Methylprednisolone

Methylprednisolone is reported as an ingredient of Methylprednisolon in the following countries:


  • Georgia

International Drug Name Search

Monday, 19 December 2011

Ampicillin Actavis




Ampicillin Actavis may be available in the countries listed below.


Ingredient matches for Ampicillin Actavis



Ampicillin

Ampicillin is reported as an ingredient of Ampicillin Actavis in the following countries:


  • Estonia

  • Latvia

  • Lithuania

Ampicillin sodium salt (a derivative of Ampicillin) is reported as an ingredient of Ampicillin Actavis in the following countries:


  • Bulgaria

International Drug Name Search

Monday, 12 December 2011

Vistide




In the US, Vistide (cidofovir systemic) is a member of the drug class purine nucleosides and is used to treat CMV Retinitis and Smallpox Vaccine Reaction.

US matches:

  • Vistide

UK matches:

  • Vistide (SPC)

Ingredient matches for Vistide



Cidofovir

Cidofovir is reported as an ingredient of Vistide in the following countries:


  • Australia

  • Austria

  • Belgium

  • Czech Republic

  • France

  • Germany

  • Italy

  • Luxembourg

  • Portugal

  • Slovenia

  • Spain

  • Sweden

  • Switzerland

  • United Kingdom

  • United States

Cidofovir dihydrate (a derivative of Cidofovir) is reported as an ingredient of Vistide in the following countries:


  • Netherlands

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 6 December 2011

Perio-Clor




Perio-Clor may be available in the countries listed below.


Ingredient matches for Perio-Clor



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Perio-Clor in the following countries:


  • Dominican Republic

International Drug Name Search

Sunday, 4 December 2011

Detralex




Detralex may be available in the countries listed below.


Ingredient matches for Detralex



Diosmin

Diosmin is reported as an ingredient of Detralex in the following countries:


  • Croatia (Hrvatska)

  • Hungary

  • Serbia

  • Slovenia

Hesperidin

Hesperidin is reported as an ingredient of Detralex in the following countries:


  • Croatia (Hrvatska)

  • Hungary

  • Serbia

  • Slovenia

International Drug Name Search

Saturday, 3 December 2011

Cipractine




Cipractine may be available in the countries listed below.


Ingredient matches for Cipractine



Cyproheptadine

Cyproheptadine is reported as an ingredient of Cipractine in the following countries:


  • Tunisia

International Drug Name Search

Thursday, 1 December 2011

Prontoket




Prontoket may be available in the countries listed below.


Ingredient matches for Prontoket



Ketoprofen

Ketoprofen is reported as an ingredient of Prontoket in the following countries:


  • Czech Republic

  • Estonia

  • Hungary

  • Latvia

  • Lithuania

  • Slovakia

International Drug Name Search

Saturday, 26 November 2011

Osteo Bi-Flex Double Strength


Generic Name: chondroitin and glucosamine (kon DROI tin and gloo KOE sa meen)

Brand Names: Cosamin DS, Osteo Bi-Flex, Osteo Bi-Flex Double Strength, Osteo Bi-Flex Triple Strength, Pryflex, Relamine, Schiff Move Free, Schiff Move Free Caplets


What is Osteo Bi-Flex Double Strength (chondroitin and glucosamine)?

Chondroitin is a naturally occurring substance formed of sugar chains. Chondroitin is believed to help the body maintain fluid and flexibility in the joints.


Glucosamine is sugar protein that is believed to help develop and renew cartilage (the hard connective tissue mainly located on bones near joints in the body), and keep it lubricated for better joint movement and flexibility.


The combination of chondroitin and glucosamine is widely used to aid in maintaining healthy joints. It is also used as a nutritional supplement in people with osteoarthritis or other inflammatory joint disorders.


Not all uses for chondroitin and glucosamine have been approved by the FDA. Chondroitin and glucosamine should not be substituted for medications prescribed for you by your doctor.

Chondroitin and glucosamine is often sold as an herbal supplement. There are no regulated manufacturing standards in place for many herbal compounds and some marketed supplements have been found to be contaminated with toxic metals or other drugs. Herbal/health supplements should be purchased from a reliable source to minimize the risk of contamination.


Chondroitin and glucosamine may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about Osteo Bi-Flex Double Strength (chondroitin and glucosamine)?


Not all uses for chondroitin and glucosamine have been approved by the FDA. Chondroitin and glucosamine should not be substituted for medications prescribed for you by your doctor.

Chondroitin and glucosamine is often sold as an herbal supplement. There are no regulated manufacturing standards in place for many herbal compounds and some marketed supplements have been found to be contaminated with toxic metals or other drugs. Herbal/health supplements should be purchased from a reliable source to minimize the risk of contamination.


Before using chondroitin and glucosamine, talk to your doctor, pharmacist, herbalist, or other healthcare provider. You may not be able to use chondroitin and glucosamine if you have diabetes, a bleeding or blood clotting disorder such as hemophilia, if you have allergies to certain drugs, if you are overweight, or if you are on a low-salt diet.


Use chondroitin and glucosamine as directed on the label, or as your healthcare provider has prescribed. Do not use this product in larger amounts or for longer than recommended.


Do not take chondroitin and glucosamine without the advice of a healthcare provider if you are using insulin, or a blood thinner such as warfarin (Coumadin). Avoid taking chitosan (usually marketed as a weight-loss product) while you are taking chondroitin and glucosamine. Chitosan can make it harder for your body to absorb chondroitin.

What should I tell my healthcare provider before taking Osteo Bi-Flex Double Strength (chondroitin and glucosamine)?


Before using chondroitin and glucosamine, talk to your doctor, pharmacist, herbalist, or other healthcare provider. You may not be able to use chondroitin and glucosamine if you have:



  • diabetes;




  • a bleeding or blood clotting disorder such as hemophilia;




  • if you have allergies to certain drugs;




  • if you are overweight; or




  • if you are on a low-salt diet.




Chondroitin and glucosamine may or may not be harmful to an unborn baby. Do not use this product without talking to a healthcare provider if you are pregnant or plan to become pregnant during treatment. It is not known whether chondroitin and glucosamine can pass into breast milk or if it could harm a nursing baby. Ask your healthcare provider before using chondroitin and glucosamine if you are breast-feeding a baby.

How should I take Osteo Bi-Flex Double Strength (chondroitin and glucosamine)?


When considering the use of herbal supplements, seek the advice of your doctor. You may also consider consulting a practitioner who is trained in the use of herbal/health supplements.


If you choose to take chondroitin and glucosamine, use it as directed on the package or as directed by your doctor, pharmacist, or other healthcare provider. Do not use more of chondroitin and glucosamine than is recommended on the label.


Chondroitin and glucosamine is usually taken 1 or 2 times per day. You may need to take the medication 3 times per day for the first couple of months of treatment. Follow your doctor's instructions.


Glucosamine may increase the glucose (sugar) levels in your blood. If you have diabetes, you may need to check your blood sugar more often while taking this medication. You may also need to adjust your insulin dosage. Do not change your dose or medication schedule without advice from your doctor.


Chondroitin and glucosamine may be only part of a complete program of treatment that also includes diet, exercise, and weight control. Follow your diet, medication, and exercise routines very closely.


Store this medication at room temperature away from moisture, heat, and light.

What happens if I miss a dose?


Take the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to take the medicine and skip the missed dose. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while taking Osteo Bi-Flex Double Strength (chondroitin and glucosamine)?


Avoid taking chitosan (usually marketed as a weight-loss product) while you are taking chondroitin and glucosamine. Chitosan can make it harder for your body to absorb chondroitin.

Osteo Bi-Flex Double Strength (chondroitin and glucosamine) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Less serious side effects may include:



  • mild nausea, upset stomach;




  • heartburn; or




  • diarrhea.



This is not a complete list of side effects and others may occur. Tell your doctor, pharmacist, herbalist, or other healthcare provider about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Osteo Bi-Flex Double Strength (chondroitin and glucosamine)?


Do not take chondroitin and glucosamine without the advice of a healthcare provider if you are using any of the following medications:

  • insulin; or




  • a blood thinner such as warfarin (Coumadin).



This list is not complete and other drugs may interact with chondroitin and glucosamine. Tell your healthcare provider about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Osteo Bi-Flex Double Strength resources


  • Osteo Bi-Flex Double Strength Use in Pregnancy & Breastfeeding
  • Osteo Bi-Flex Double Strength Drug Interactions
  • 0 Reviews for Osteo Bi-Flex Double Strength - Add your own review/rating


  • Osteo Bi-Flex Triple Strength caplets

  • Relamine MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Osteo Bi-Flex Double Strength with other medications


  • Dietary Supplementation
  • Osteoarthritis


Where can I get more information?


  • Consult with a licensed healthcare professional before using any herbal/health supplement. Whether you are treated by a medical doctor or a practitioner trained in the use of natural medicines/supplements, make sure all your healthcare providers know about all of your medical conditions and treatments.


Pantoprazol gamma




Pantoprazol gamma may be available in the countries listed below.


Ingredient matches for Pantoprazol gamma



Pantoprazole

Pantoprazole sodium (a derivative of Pantoprazole) is reported as an ingredient of Pantoprazol gamma in the following countries:


  • Germany

International Drug Name Search

Tuesday, 22 November 2011

ChiRhoStim


ChiRhoStim is a brand name of secretin, approved by the FDA in the following formulation(s):


CHIRHOSTIM (secretin synthetic human - for solution; intravenous)



  • Manufacturer: CHIRHOCLIN

    Approval date: April 9, 2004

    Strength(s): 16MCG/VIAL [RLD]


  • Manufacturer: CHIRHOCLIN

    Approval date: June 21, 2007

    Strength(s): 40MCG/VIAL

Has a generic version of ChiRhoStim been approved?


No. There is currently no therapeutically equivalent version of ChiRhoStim available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of ChiRhoStim. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with ChiRhoStim.

See also...

    Pacific Buspirone




    Pacific Buspirone may be available in the countries listed below.


    Ingredient matches for Pacific Buspirone



    Buspirone

    Buspirone hydrochloride (a derivative of Buspirone) is reported as an ingredient of Pacific Buspirone in the following countries:


    • New Zealand

    International Drug Name Search

    Wednesday, 16 November 2011

    Durol




    Durol may be available in the countries listed below.


    Ingredient matches for Durol



    Carvedilol

    Carvedilol is reported as an ingredient of Durol in the following countries:


    • Bangladesh

    International Drug Name Search

    Saturday, 12 November 2011

    Viveo




    Viveo may be available in the countries listed below.


    Ingredient matches for Viveo



    Tolperisone

    Tolperisone hydrochloride (a derivative of Tolperisone) is reported as an ingredient of Viveo in the following countries:


    • Germany

    International Drug Name Search

    Thursday, 10 November 2011

    Supreme




    Supreme may be available in the countries listed below.


    Ingredient matches for Supreme



    Sulfamethoxazole

    Sulfamethoxazole is reported as an ingredient of Supreme in the following countries:


    • Peru

    Trimethoprim

    Trimethoprim is reported as an ingredient of Supreme in the following countries:


    • Peru

    International Drug Name Search

    Tuesday, 8 November 2011

    Toltem




    Toltem may be available in the countries listed below.


    Ingredient matches for Toltem



    Tolterodine

    Tolterodine tartrate (a derivative of Tolterodine) is reported as an ingredient of Toltem in the following countries:


    • Argentina

    International Drug Name Search

    Sunday, 6 November 2011

    Boniva


    Boniva is a brand name of ibandronate, approved by the FDA in the following formulation(s):


    BONIVA (ibandronate sodium - injectable; intravenous)



    • Manufacturer: ROCHE

      Approval date: January 6, 2006

      Strength(s): EQ 3MG BASE/3ML [RLD]

    BONIVA (ibandronate sodium - tablet; oral)



    • Manufacturer: ROCHE

      Approval date: March 24, 2005

      Strength(s): EQ 150MG BASE [RLD]

    Has a generic version of Boniva been approved?


    No. There is currently no therapeutically equivalent version of Boniva available.


    Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Boniva. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

    See also: About generic drugs.




    Related Patents


    Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




    • Diphosphonate derivatives, pharmaceutical compositions and methods of use
      Patent 4,927,814
      Issued: May 22, 1990
      Inventor(s): Gall; Rudi & Bosies; Elmar
      Assignee(s): Boehringer Mannheim GmbH
      The present invention provides disphosphonates of the general formula: ##STR1## wherein R.sub.1 is a straight-chain or branched, saturated or unsaturated aliphatic hydrocarbon radical of 1-9 carbon atoms which is optionally substituted by phenyl or cyclohexyl, R.sub.2 is cyclohexyl or cyclohexylmethyl, benzyl or a straight-chained or branched, saturated or unsaturated aliphatic hydrocarbon of 4 to 18 carbon atoms which is optionally substituted by phenyl or oxygen wherein the oxygen can be esterified or etherified, R.sub.3 is hydrogen or a straight-chain or branched alkyl of 1-4 carbon atoms, X is a straight-chain or branched alkylene chain of 1-6 carbon atoms and Y is hydrogen, hydroxyl or an amino group optionally substituted by alkyl radicals of 1-6 carbon atoms; as well as the pharmacologically acceptable salts thereof. The present invention also provides processes for the preparation of these diphosphonic acid derivatives and pharmaceutical compositions containing them for the prophyllaxis treatment of diseases or disturbances of calcium metabolism such as osteoporsis, Pagets disease, Bechterew's disease, bone metastases, urolithiasis, heterotropic ossifications, rheumatoid arthritis, osteoarthritis and degenerative arthrosis.
      Patent expiration dates:

      • March 17, 2012
        ✓ 
        Patent use: TREATMENT AND PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
        ✓ 
        Drug substance
        ✓ 
        Drug product


      • March 17, 2012
        ✓ 
        Patent use: TREATMENT AND PREVENTION OF OSTEOPOROSIS
        ✓ 
        Drug substance
        ✓ 
        Drug product




    • Pharmaceutical agents containing diphosphonic acids and salts thereof
      Patent 5,662,918
      Issued: September 2, 1997
      Inventor(s): Winter; Gerhard & Pichler; Bernhard & Woog; Heinrich & Heller; Werner
      Assignee(s): Boehringer Mannheim GmbH
      The invention concerns pharmaceutical preparations that are stable on storage, which contain at least one diphosphonic acid and/or at least one physiologically acceptable salt of such an acid as the active substance.
      Patent expiration dates:

      • September 2, 2014
        ✓ 
        Drug product




    • Oral pharmaceutical preparation containing ibandronat
      Patent 6,143,326
      Issued: November 7, 2000
      Inventor(s): Mockel; Jorn & Gabel; Rolf-Dieter & Woog; Heinrich
      Assignee(s): Roche Diagnostics GmbH
      The invention is directed to well-tolerated pharmaceutical compositions for oral application, containing ibandronate or a physiologically tolerable salt thereof as active substance, the administration form consisting of an active substance-containing inner portion enclosed in such fashion by a coat free of active substance that rapid release of the active substance takes place.
      Patent expiration dates:

      • April 21, 2017
        ✓ 
        Patent use: TREATMENT AND PREVENTION OF OSTEOPOROSIS




    • Pharmaceutical composition containing diphosphonic acid or salt thereof
      Patent 6,294,196
      Issued: September 25, 2001
      Inventor(s): Gabel; Rolf-Dieter & Preis; Walter & Woog; Heinrich
      Assignee(s): Hoffmann-La Roche Inc.
      The invention relates to a solid pharmaceutical form of administration containing a diphosphonic acid or a physiologically compatible salt thereof as the active substance, wherein the active substance is present in granulate form, optionally together with pharmaceutical adjuvants in the inner phase, and the outer phase contains a lubricant in the form of less than 5% by weight of stearic acid relative to the total weight of the form of administration.
      Patent expiration dates:

      • October 7, 2019
        ✓ 
        Drug product




    • Method of treatment using bisphosphonic acid
      Patent 7,192,938
      Issued: March 20, 2007
      Inventor(s): Bauss; Frieder & Pichler; Bernhard & Turley; Stephen
      Assignee(s): Hoffmann-La Roche Inc.
      The present invention refers to a pharmaceutical composition of a bisphosphonic acid or salt thereof, and an excipient thereof, and a method of treating disorder characterized by pathologically increased bone resorption comprising orally administering at least 150% of the expected efficious daily dose of a bisphosphonic acid or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients thereof and administering the dose at a period of one two or three consecutive days per month.
      Patent expiration dates:

      • May 6, 2023
        ✓ 
        Patent use: TREATMENT AND PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN BY ONCE-MONTHLY ORAL ADMINISTRATION OF IBANDRONATE SODIUM MONOHYDRATE EQUIVALENT TO 150MG OF IBANDRONIC ACID




    • Method of treatment using bisphosphonic acid
      Patent 7,410,957
      Issued: August 12, 2008
      Inventor(s): Bauss; Frieder & Pichler; Bernhard & Turley; Stephen
      Assignee(s): Hoffmann-La Roche Inc.
      The present invention refers to a pharmaceutical composition of a bisphosphonic acid or salt thereof, and an excipient thereof, and a method of treating disorder characterized by pathologically increased bone resorption comprising orally administering at least 150% of the expected efficious daily dose of a bisphosphonic acid or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients thereof and administering the dose at a period of one two or three consecutive days per month.
      Patent expiration dates:

      • May 6, 2023
        ✓ 
        Patent use: TREATMENT AND PREVENTION OF OSTEOPOROSIS




    • Method of treatment using bisphosphonic acid
      Patent 7,718,634
      Issued: May 18, 2010
      Inventor(s): Bauss; Frieder & Pichler; Bernhard & Turley; Stephen
      Assignee(s): Hoffman-La Roche Inc.
      The present invention refers to a pharmaceutical composition of a bisphosphonic acid or salt thereof, and an excipient thereof, and a method of treating disorder characterized by pathologically increased bone resorption comprising orally administering at least 150% of the expected efficious daily dose of a bisphosphonic acid or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients thereof and administering the dose at a period of one two or three consecutive days per month.
      Patent expiration dates:

      • May 6, 2023
        ✓ 
        Patent use: TREATMENT AND PREVENTION OF OSTEOPOROSIS



    See also...

    • Boniva Consumer Information (Drugs.com)
    • Boniva Consumer Information (Drugs.com)
    • Boniva Consumer Information (Wolters Kluwer)
    • Boniva Consumer Information (Cerner Multum)
    • Boniva Advanced Consumer Information (Micromedex)
    • Boniva Intravenous Advanced Consumer Information (Micromedex)
    • Boniva AHFS DI Monographs (ASHP)
    • Boniva IV Injection Consumer Information (Drugs.com)
    • Ibandronate Consumer Information (Wolters Kluwer)
    • Ibandronate Consumer Information (Cerner Multum)
    • Bondronat Advanced Consumer Information (Micromedex)
    • Ibandronate Intravenous Advanced Consumer Information (Micromedex)
    • Ibandronate Oral, Injection Advanced Consumer Information (Micromedex)
    • Ibandronate Sodium AHFS DI Monographs (ASHP)

    Macrosan




    Macrosan may be available in the countries listed below.


    Ingredient matches for Macrosan



    Nitrofurantoin

    Nitrofurantoin is reported as an ingredient of Macrosan in the following countries:


    • Chile

    International Drug Name Search

    Saturday, 5 November 2011

    CO Etidronate




    CO Etidronate may be available in the countries listed below.


    Ingredient matches for CO Etidronate



    Etidronic Acid

    Etidronic Acid is reported as an ingredient of CO Etidronate in the following countries:


    • Canada

    International Drug Name Search

    Friday, 4 November 2011

    Orciprenaline Sulphate




    Orciprenaline Sulphate may be available in the countries listed below.


    Ingredient matches for Orciprenaline Sulphate



    Orciprenaline

    Orciprenaline Sulphate (BANM) is also known as Orciprenaline (Rec.INN)

    International Drug Name Search

    Glossary

    BANMBritish Approved Name (Modified)
    Rec.INNRecommended International Nonproprietary Name (World Health Organization)

    Click for further information on drug naming conventions and International Nonproprietary Names.

    Tuesday, 1 November 2011

    Pyridinol Carbamate




    Pyridinol Carbamate may be available in the countries listed below.


    Ingredient matches for Pyridinol Carbamate



    Pyricarbate

    Pyridinol Carbamate (JAN) is also known as Pyricarbate (Rec.INN)

    International Drug Name Search

    Glossary

    JANJapanese Accepted Name
    Rec.INNRecommended International Nonproprietary Name (World Health Organization)

    Click for further information on drug naming conventions and International Nonproprietary Names.

    Tuesday, 11 October 2011

    Penicilina V Sandoz




    Penicilina V Sandoz may be available in the countries listed below.


    Ingredient matches for Penicilina V Sandoz



    Phenoxymethylpenicillin

    Phenoxymethylpenicillin is reported as an ingredient of Penicilina V Sandoz in the following countries:


    • Argentina

    International Drug Name Search

    Thursday, 6 October 2011

    Oprelevkin




    Scheme

    Rec.INN

    ATC (Anatomical Therapeutic Chemical Classification)

    L03AC02

    CAS registry number (Chemical Abstracts Service)

    0145941-26-0

    Chemical Formula

    C854-H1411-N253-O235-S2

    Molecular Weight

    19047

    Therapeutic Category

    Immunomodulator

    Chemical Name

    2-178-Interleukin 11 (human clone pXM/IL-11)

    Foreign Names

    • Oprelvekinum (Latin)
    • Oprelvekin (German)
    • Oprelvékine (French)
    • Oprelvekina (Spanish)

    Generic Names

    • Oprelvekin (OS: USAN)
    • Rhil-11 (IS)

    Brand Names

    • Neumega
      Wyeth, Brazil; Wyeth, Chile; Wyeth, Colombia; Wyeth, United States; Wyeth, Venezuela

    International Drug Name Search

    Glossary

    ISInofficial Synonym
    OSOfficial Synonym
    Rec.INNRecommended International Nonproprietary Name (World Health Organization)
    USANUnited States Adopted Name

    Click for further information on drug naming conventions and International Nonproprietary Names.

    Tuesday, 4 October 2011

    Zelian




    Zelian may be available in the countries listed below.


    Ingredient matches for Zelian



    Buflomedil

    Buflomedil hydrochloride (a derivative of Buflomedil) is reported as an ingredient of Zelian in the following countries:


    • Greece

    International Drug Name Search

    Saturday, 1 October 2011

    B-Complex/Vitamin C/Folic Acid/Iron/Minerals


    Pronunciation: VYE-ta-min C/FOE-lik AS-id/EYE-urn/MIN-er-als
    Generic Name: B-Complex/Vitamin C/Folic Acid/Iron/Minerals
    Brand Name: Examples include Hemocyte Plus and Ferrocite Plus

    Accidental overdose of products that contain iron is a leading cause of fatal poisoning in children younger than 6 years old. Keep this and all medicines out of the reach of children. In case of accidental ingestion, call the poison control center or a doctor at once.





    B-Complex/Vitamin C/Folic Acid/Iron/Minerals is used for:

    Preventing and treating certain types of anemia (eg, caused by low blood iron levels, poor nutrition). It may also be used for other conditions as determined by your doctor.


    B-Complex/Vitamin C/Folic Acid/Iron/Minerals is a vitamin, folic acid, iron, and mineral combination. It works by providing vitamins, folic acid, iron, and minerals to the body.


    Do NOT use B-Complex/Vitamin C/Folic Acid/Iron/Minerals if:


    • you are allergic to any ingredient in B-Complex/Vitamin C/Folic Acid/Iron/Minerals

    • you have certain iron metabolism problems (eg, hemosiderosis, hemochromatosis), hemolytic anemia, pernicious anemia, or you have high levels of iron in your blood

    Contact your doctor or health care provider right away if any of these apply to you.



    Before using B-Complex/Vitamin C/Folic Acid/Iron/Minerals:


    Some medical conditions may interact with B-Complex/Vitamin C/Folic Acid/Iron/Minerals. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


    • if you are pregnant, planning to become pregnant, or are breast-feeding

    • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

    • if you have allergies to medicines, foods, or other substances

    • if you have sickle cell anemia or a history of other blood problems (eg, porphyria, thalassemia)

    • if you have a peptic ulcer or stomach or bowel problems (eg, ulcerative colitis)

    • if you have glucose-6-phosphate-dehydrogenase (G6PD) deficiency, have a bleeding problem, have had multiple blood transfusions, or are receiving dialysis

    • if you have a history of seizures

    Some MEDICINES MAY INTERACT with B-Complex/Vitamin C/Folic Acid/Iron/Minerals. Tell your health care provider if you are taking any other medicines, especially any of the following:


    • Fluorouracil because the risk of its side effects may be increased by B-Complex/Vitamin C/Folic Acid/Iron/Minerals

    • Doxycycline, hydantoins (eg, phenytoin), mycophenolate, penicillamine, or thyroid hormones (eg, levothyroxine) because their effectiveness may be decreased by B-Complex/Vitamin C/Folic Acid/Iron/Minerals

    This may not be a complete list of all interactions that may occur. Ask your health care provider if B-Complex/Vitamin C/Folic Acid/Iron/Minerals may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


    How to use B-Complex/Vitamin C/Folic Acid/Iron/Minerals:


    Use B-Complex/Vitamin C/Folic Acid/Iron/Minerals as directed by your doctor. Check the label on the medicine for exact dosing instructions.


    • Take B-Complex/Vitamin C/Folic Acid/Iron/Minerals by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.

    • If you also take antacids, bisphosphonates (eg, etidronate), cephalosporins (eg, cefdinir), doxycycline, hydantoins (eg, phenytoin), levodopa, methyldopa, penicillamine, quinolones (eg, ciprofloxacin, levofloxacin), tetracyclines (eg, minocycline), or thyroid hormones (eg, levothyroxine), ask your doctor or pharmacist how to take them with B-Complex/Vitamin C/Folic Acid/Iron/Minerals.

    • If you miss a dose of B-Complex/Vitamin C/Folic Acid/Iron/Minerals, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

    Ask your health care provider any questions you may have about how to use B-Complex/Vitamin C/Folic Acid/Iron/Minerals.



    Important safety information:


    • Do not take more than the recommended dose without checking with your doctor.

    • Do not take large doses of vitamins (megadoses or megavitamin therapy) while you use B-Complex/Vitamin C/Folic Acid/Iron/Minerals unless your doctor tells you to.

    • B-Complex/Vitamin C/Folic Acid/Iron/Minerals has folic acid and iron in it. Before you start any new medicine, check the label to see if it has folic acid or iron in it too. If it does or if you are not sure, check with your doctor or pharmacist.

    • B-Complex/Vitamin C/Folic Acid/Iron/Minerals has iron in it. Iron overdose is a leading cause of fatal poisoning in children younger than 6 years of age. In case of an overdose, call a doctor or poison control center right away.

    • This product may contain tartrazine dye (FD & C Yellow No. 5). This may cause an allergic reaction in some patients. If you have ever had an allergic reaction to tartrazine, ask your pharmacist if your product has tartrazine in it.

    • B-Complex/Vitamin C/Folic Acid/Iron/Minerals may interfere with certain lab tests, including tests used to check for blood in the stool. Be sure your doctor and lab personnel know you are taking B-Complex/Vitamin C/Folic Acid/Iron/Minerals.

    • Lab tests, including hematocrit, hemoglobin levels, and blood iron levels, may be performed while you use B-Complex/Vitamin C/Folic Acid/Iron/Minerals. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

    • B-Complex/Vitamin C/Folic Acid/Iron/Minerals should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

    • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using B-Complex/Vitamin C/Folic Acid/Iron/Minerals while you are pregnant. B-Complex/Vitamin C/Folic Acid/Iron/Minerals is found in breast milk. If you are or will be breast-feeding while you use B-Complex/Vitamin C/Folic Acid/Iron/Minerals, check with your doctor. Discuss any possible risks to your baby.


    Possible side effects of B-Complex/Vitamin C/Folic Acid/Iron/Minerals:


    All medicines may cause side effects, but many people have no, or minor side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



    Constipation; dark or green stools; diarrhea; nausea; stomach pain; vomiting.



    Seek medical attention right away if any of these SEVERE side effects occur:

    Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); black, tarry, or bloody stools; severe or persistent stomach pain.



    This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.



    If OVERDOSE is suspected:


    Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include black, tarry, or bloody stools; blue or unusually pale skin; drowsiness or dizziness; fast heartbeat; increased thirst or urination; seizures; severe or persistent nausea, vomiting, diarrhea, or stomach pain; sluggishness; vomiting blood; weakness.


    Proper storage of B-Complex/Vitamin C/Folic Acid/Iron/Minerals:

    Store B-Complex/Vitamin C/Folic Acid/Iron/Minerals at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep B-Complex/Vitamin C/Folic Acid/Iron/Minerals out of the reach of children and away from pets.


    General information:


    • If you have any questions about B-Complex/Vitamin C/Folic Acid/Iron/Minerals, please talk with your doctor, pharmacist, or other health care provider.

    • B-Complex/Vitamin C/Folic Acid/Iron/Minerals is to be used only by the patient for whom it is prescribed. Do not share it with other people.

    • If your symptoms do not improve or if they become worse, check with your doctor.

    • Check with your pharmacist about how to dispose of unused medicine.

    This information is a summary only. It does not contain all information about B-Complex/Vitamin C/Folic Acid/Iron/Minerals. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



    Issue Date: February 1, 2012

    Database Edition 12.1.1.002

    Copyright © 2012 Wolters Kluwer Health, Inc.

    More B-Complex/Vitamin C/Folic Acid/Iron/Minerals resources


    • B-Complex/Vitamin C/Folic Acid/Iron/Minerals Use in Pregnancy & Breastfeeding
    • Drug Images
    • B-Complex/Vitamin C/Folic Acid/Iron/Minerals Drug Interactions
    • B-Complex/Vitamin C/Folic Acid/Iron/Minerals Support Group
    • 11 Reviews for B-Complex/Vitamin C/Folic Acid/Iron/Minerals - Add your own review/rating


    Compare B-Complex/Vitamin C/Folic Acid/Iron/Minerals with other medications


    • Anemia
    • Vitamin/Mineral Supplementation and Deficiency

    Tuesday, 27 September 2011

    Ketotisan




    Ketotisan may be available in the countries listed below.


    Ingredient matches for Ketotisan



    Ketotifen

    Ketotifen fumarate (a derivative of Ketotifen) is reported as an ingredient of Ketotisan in the following countries:


    • Austria

    International Drug Name Search

    Oxaliplatino




    Oxaliplatino may be available in the countries listed below.


    Ingredient matches for Oxaliplatino



    Oxaliplatin

    Oxaliplatin is reported as an ingredient of Oxaliplatino in the following countries:


    • Chile

    • Peru

    International Drug Name Search

    Sunday, 25 September 2011

    Rutoside




    Scheme

    Rec.INN

    ATC (Anatomical Therapeutic Chemical Classification)

    C05CA01

    CAS registry number (Chemical Abstracts Service)

    0000153-18-4

    Chemical Formula

    C27-H30-O16

    Molecular Weight

    610

    Therapeutic Category

    Capillary stabilizing agent

    Chemical Name

    4H-1-Benzopyran-4-one, 3-[[6-O-(6-deoxy-α-L-mannopyranosyl)-ß-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-

    Foreign Names

    • Rutosidum (Latin)
    • Rutosid (German)
    • Rutoside (French)
    • Rutosido (Spanish)

    Generic Names

    • Rutin (OS: JAN)
    • Rutoside (OS: BAN, DCF, DCIT)
    • Rutinum (IS)
    • Sclerutin (IS)
    • Rutine (PH: Ph. Franç. Xe édit)
    • Rutoside Trihydrate (PH: Ph. Eur. 6, BP 2010)
    • Rutosidum (PH: Ph. Helv. 8)
    • Rutosidum trihydricum (PH: Ph. Eur. 6)

    Brand Names

    • Agrypin (Rutoside and Ascorbic Acid)
      Polfa Tarchomin, Poland


    • Ascorutin (Rutoside and Ascorbic Acid)
      Zentiva, Slovakia


    • Cebion plus Rutin (Rutoside and Ascorbic Acid)
      Merck, Austria


    • Cerutin (Rutoside and Ascorbic Acid)
      Polfarmex, Poland


    • Meflavon
      Mekophar, Vietnam


    • Rutin
      Rekah, Israel; Twardy, Germany


    • RutinaC (Rutoside and Ascorbic Acid)
      Aflofarm, Poland


    • Rutinoscorbin (Rutoside and Ascorbic Acid)
      GlaxoSmithKline, Poland


    • Rutovit C (Rutoside and Ascorbic Acid)
      Teva, Poland


    • Venaron
      Teguhsindo, Indonesia


    • Venoruton
      Novartis, United Arab Emirates; Novartis, Bahrain; Novartis, Brazil; Novartis, Iraq; Novartis, Jordan; Novartis, Kuwait; Novartis, Lebanon; Novartis, Luxembourg; Novartis, Latvia; Novartis, Oman; Novartis, Qatar; Novartis, Russian Federation; Novartis, Saudi Arabia; Novartis, Yemen; Novartis Consumer Health, Egypt

    International Drug Name Search

    Glossary

    BANBritish Approved Name
    DCFDénomination Commune Française
    DCITDenominazione Comune Italiana
    ISInofficial Synonym
    JANJapanese Accepted Name
    OSOfficial Synonym
    PHPharmacopoeia Name
    Rec.INNRecommended International Nonproprietary Name (World Health Organization)

    Click for further information on drug naming conventions and International Nonproprietary Names.

    Saturday, 24 September 2011

    Nefrofer




    Nefrofer may be available in the countries listed below.


    Ingredient matches for Nefrofer



    Iron Sucrose

    Iron Sucrose is reported as an ingredient of Nefrofer in the following countries:


    • Indonesia

    International Drug Name Search

    Tuesday, 20 September 2011

    Restoril




    In the US, Restoril (temazepam systemic) is a member of the drug class benzodiazepines and is used to treat Insomnia.

    US matches:

    • Restoril

    Ingredient matches for Restoril



    Temazepam

    Temazepam is reported as an ingredient of Restoril in the following countries:


    • Canada

    • United States

    International Drug Name Search

    Accuretic




    In the US, Accuretic (hydrochlorothiazide/quinapril systemic) is a member of the drug class antihypertensive combinations and is used to treat High Blood Pressure.

    US matches:

    • Accuretic

    UK matches:

    • Accuretic 10/12.5mg Tablets (SPC)

    Ingredient matches for Accuretic



    Hydrochlorothiazide

    Hydrochlorothiazide is reported as an ingredient of Accuretic in the following countries:


    • Australia

    • Belgium

    • Canada

    • Colombia

    • Greece

    • Italy

    • Peru

    • South Africa

    • Switzerland

    • United Kingdom

    • United States

    Quinapril

    Quinapril is reported as an ingredient of Accuretic in the following countries:


    • Ireland

    • United Kingdom

    Quinapril hydrochloride (a derivative of Quinapril) is reported as an ingredient of Accuretic in the following countries:


    • Argentina

    • Australia

    • Belgium

    • Canada

    • Colombia

    • Greece

    • Italy

    • Peru

    • South Africa

    • Switzerland

    • United Kingdom

    • United States

    International Drug Name Search

    Glossary

    SPC Summary of Product Characteristics (UK)

    Click for further information on drug naming conventions and International Nonproprietary Names.

    Monday, 19 September 2011

    Procaine-Stella




    Procaine-Stella may be available in the countries listed below.


    Ingredient matches for Procaine-Stella



    Procaine

    Procaine hydrochloride (a derivative of Procaine) is reported as an ingredient of Procaine-Stella in the following countries:


    • Luxembourg

    International Drug Name Search

    Sotalol HCl Sandoz




    Sotalol HCl Sandoz may be available in the countries listed below.


    Ingredient matches for Sotalol HCl Sandoz



    Sotalol

    Sotalol hydrochloride (a derivative of Sotalol) is reported as an ingredient of Sotalol HCl Sandoz in the following countries:


    • Netherlands

    International Drug Name Search

    Sunday, 18 September 2011

    Pamol Flash




    Pamol Flash may be available in the countries listed below.


    Ingredient matches for Pamol Flash



    Paracetamol

    Paracetamol is reported as an ingredient of Pamol Flash in the following countries:


    • Denmark

    International Drug Name Search

    Thursday, 15 September 2011

    Onylac




    Onylac may be available in the countries listed below.


    Ingredient matches for Onylac



    Ciclopirox

    Ciclopirox is reported as an ingredient of Onylac in the following countries:


    • Latvia

    International Drug Name Search

    Pamdosa




    Pamdosa may be available in the countries listed below.


    Ingredient matches for Pamdosa



    Pamidronic Acid

    Pamidronic Acid disodium salt (a derivative of Pamidronic Acid) is reported as an ingredient of Pamdosa in the following countries:


    • Argentina

    International Drug Name Search

    Wednesday, 14 September 2011

    Promisec




    Promisec may be available in the countries listed below.


    Ingredient matches for Promisec



    Omeprazole

    Omeprazole is reported as an ingredient of Promisec in the following countries:


    • India

    International Drug Name Search

    Tuesday, 13 September 2011

    Simvar




    Simvar may be available in the countries listed below.


    Ingredient matches for Simvar



    Simvastatin

    Simvastatin is reported as an ingredient of Simvar in the following countries:


    • Australia

    International Drug Name Search

    Stanalin




    Stanalin may be available in the countries listed below.


    Ingredient matches for Stanalin



    Mefenamic Acid

    Mefenamic Acid is reported as an ingredient of Stanalin in the following countries:


    • Indonesia

    International Drug Name Search

    Thursday, 25 August 2011

    Aloperidolo




    Aloperidolo may be available in the countries listed below.


    Ingredient matches for Aloperidolo



    Haloperidol

    Aloperidolo (DCIT) is known as Haloperidol in the US.

    International Drug Name Search

    Glossary

    DCITDenominazione Comune Italiana

    Click for further information on drug naming conventions and International Nonproprietary Names.

    Monday, 22 August 2011

    Captopril Tamarang




    Captopril Tamarang may be available in the countries listed below.


    Ingredient matches for Captopril Tamarang



    Captopril

    Captopril is reported as an ingredient of Captopril Tamarang in the following countries:


    • Spain

    International Drug Name Search

    Friday, 19 August 2011

    Lasitone




    Lasitone may be available in the countries listed below.


    Ingredient matches for Lasitone



    Furosemide

    Furosemide is reported as an ingredient of Lasitone in the following countries:


    • Italy

    Spironolactone

    Spironolactone is reported as an ingredient of Lasitone in the following countries:


    • Italy

    International Drug Name Search

    Sunday, 7 August 2011

    Carter's Little Pills




    Ingredient matches for Carter's Little Pills



    Bisacodyl

    Bisacodyl is reported as an ingredient of Carter's Little Pills in the following countries:


    • United States

    International Drug Name Search

    Wednesday, 3 August 2011

    Helozym




    Helozym may be available in the countries listed below.


    Ingredient matches for Helozym



    Clarithromycin

    Clarithromycin is reported as an ingredient of Helozym in the following countries:


    • Costa Rica

    International Drug Name Search

    Tuesday, 2 August 2011

    Metformin Leciva




    Metformin Leciva may be available in the countries listed below.


    Ingredient matches for Metformin Leciva



    Metformin

    Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Metformin Leciva in the following countries:


    • Czech Republic

    International Drug Name Search

    Sunday, 31 July 2011

    Psiquial




    Psiquial may be available in the countries listed below.


    Ingredient matches for Psiquial



    Fluoxetine

    Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Psiquial in the following countries:


    • Brazil

    International Drug Name Search

    Wednesday, 20 July 2011

    Alendronat Spirig




    Alendronat Spirig may be available in the countries listed below.


    Ingredient matches for Alendronat Spirig



    Alendronic Acid

    Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Alendronat Spirig in the following countries:


    • Switzerland

    International Drug Name Search

    Tuesday, 19 July 2011

    Improntal Topico




    Improntal Topico may be available in the countries listed below.


    Ingredient matches for Improntal Topico



    Piroxicam

    Piroxicam is reported as an ingredient of Improntal Topico in the following countries:


    • Spain

    International Drug Name Search

    Friday, 8 July 2011

    Betamethason




    Betamethason may be available in the countries listed below.


    Ingredient matches for Betamethason



    Betamethasone

    Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Betamethason in the following countries:


    • Netherlands

    International Drug Name Search

    Tuesday, 28 June 2011

    Fluorcalcic




    Fluorcalcic may be available in the countries listed below.


    Ingredient matches for Fluorcalcic



    Sodium Fluoride

    Sodium Fluoride is reported as an ingredient of Fluorcalcic in the following countries:


    • Czech Republic

    International Drug Name Search

    Wednesday, 22 June 2011

    Neosayomol




    Neosayomol may be available in the countries listed below.


    Ingredient matches for Neosayomol



    Diphenhydramine

    Diphenhydramine hydrochloride (a derivative of Diphenhydramine) is reported as an ingredient of Neosayomol in the following countries:


    • Spain

    International Drug Name Search

    Tuesday, 21 June 2011

    Ketoprofene




    Ketoprofene may be available in the countries listed below.


    Ingredient matches for Ketoprofene



    Ketoprofen

    Ketoprofene (DCIT) is known as Ketoprofen in the US.

    International Drug Name Search

    Glossary

    DCITDenominazione Comune Italiana

    Click for further information on drug naming conventions and International Nonproprietary Names.

    Saturday, 18 June 2011

    Enalapril Heumann




    Enalapril Heumann may be available in the countries listed below.


    Ingredient matches for Enalapril Heumann



    Enalapril

    Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril Heumann in the following countries:


    • Germany

    International Drug Name Search

    Friday, 17 June 2011

    Dalfaz Uno




    Dalfaz Uno may be available in the countries listed below.


    Ingredient matches for Dalfaz Uno



    Alfuzosin

    Alfuzosin hydrochloride (a derivative of Alfuzosin) is reported as an ingredient of Dalfaz Uno in the following countries:


    • Poland

    International Drug Name Search

    Wednesday, 15 June 2011

    Aquex




    Aquex may be available in the countries listed below.


    Ingredient matches for Aquex



    Xipamide

    Xipamide is reported as an ingredient of Aquex in the following countries:


    • Germany

    International Drug Name Search

    Lévosimendan




    Lévosimendan may be available in the countries listed below.


    Ingredient matches for Lévosimendan



    Levosimendan

    Lévosimendan (DCF) is also known as Levosimendan (Rec.INN)

    International Drug Name Search

    Glossary

    DCFDénomination Commune Française
    Rec.INNRecommended International Nonproprietary Name (World Health Organization)

    Click for further information on drug naming conventions and International Nonproprietary Names.

    Tuesday, 14 June 2011

    Lovasterol




    Lovasterol may be available in the countries listed below.


    Ingredient matches for Lovasterol



    Lovastatin

    Lovastatin is reported as an ingredient of Lovasterol in the following countries:


    • Colombia

    • Latvia

    • Poland

    International Drug Name Search

    Sunday, 12 June 2011

    Roxidura




    Roxidura may be available in the countries listed below.


    Ingredient matches for Roxidura



    Roxithromycin

    Roxithromycin is reported as an ingredient of Roxidura in the following countries:


    • Germany

    International Drug Name Search

    Wednesday, 8 June 2011

    Carmozacine




    Carmozacine may be available in the countries listed below.


    Ingredient matches for Carmozacine



    Camostat

    Camostat mesilate (a derivative of Camostat) is reported as an ingredient of Carmozacine in the following countries:


    • Japan

    International Drug Name Search

    Tuesday, 24 May 2011

    Omeprazole/Sodium Bicarbonate


    Pronunciation: oh-MEP-ra-zole/SOE-dee-um bye-KAR-bo-nate
    Generic Name: Omeprazole/Sodium Bicarbonate
    Brand Name: Examples include Zegerid and Zegerid OTC


    Omeprazole/Sodium Bicarbonate is used for:

    Treating heartburn or irritation of the esophagus caused by gastroesophageal reflux disease (GERD). It may also be used for short-term treatment of ulcers of the stomach or small intestine. It may also be used to decrease the risk of stomach bleeding in severely ill patients. It may also be used for other conditions as determined by your doctor.


    Omeprazole/Sodium Bicarbonate is a proton pump inhibitor (PPI) and sodium bicarbonate combination. The PPI works by decreasing the amount of acid produced in the stomach. The sodium bicarbonate works by slowing the breakdown of the PPI in the stomach, which helps to increase absorption of the PPI.


    Do NOT use Omeprazole/Sodium Bicarbonate if:


    • you are allergic to any ingredient in Omeprazole/Sodium Bicarbonate

    • you have low blood calcium levels or metabolic alkalosis

    • you are taking dasatinib, certain HIV protease inhibitors (eg, atazanavir, nelfinavir), rifampin, or St. John's wort.

    Contact your doctor or health care provider right away if any of these apply to you.



    Before using Omeprazole/Sodium Bicarbonate:


    Some medical conditions may interact with Omeprazole/Sodium Bicarbonate. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


    • if you are pregnant, planning to become pregnant, or are breast-feeding

    • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

    • if you have allergies to medicines, foods, or other substances

    • if you have trouble or pain swallowing food; black, tarry, or bloody stools; or vomit that looks like blood or coffee grounds

    • if you have had heartburn for more than 3 months

    • if you have heartburn with lightheadedness, sweating, or dizziness

    • if you have frequent chest pain, frequent wheezing (especially with heartburn), unexplained weight loss, nausea or vomiting, or stomach pain

    • if you have chest or shoulder pain with shortness of breath; sweating; pain spreading to the arms, neck, or shoulders; or lightheadedness

    • if you are on a low-salt (sodium) diet

    • if you have liver problems, stomach or bowel cancer, or undiagnosed bleeding from the rectum

    • if you have Bartter syndrome, low blood potassium or magnesium levels, acid-base balance problems, or respiratory alkalosis

    • if you have osteoporosis (weak bones), a family history of osteoporosis, or other risk factors for osteoporosis (eg, smoking, poor nutrition)

    Some MEDICINES MAY INTERACT with Omeprazole/Sodium Bicarbonate. Tell your health care provider if you are taking any other medicines, especially any of the following:


    • Diuretics (eg, furosemide, hydrochlorothiazide) because the risk of low blood magnesium levels may be increased

    • Voriconazole because it may increase the risk of Omeprazole/Sodium Bicarbonate's side effects

    • Ginkgo biloba, rifampin, or St. John's wort because they may decrease Omeprazole/Sodium Bicarbonate's effectiveness

    • Anticoagulants (eg, warfarin), benzodiazepines (eg, diazepam), cilostazol, cyclosporine, digoxin, disulfiram, phenytoin, saquinavir, or tacrolimus because the risk of their side effects may be increased by Omeprazole/Sodium Bicarbonate

    • Ampicillins, azole antifungals (eg, ketoconazole), clopidogrel, HIV protease inhibitors (eg, atazanavir , nelfinavir), iron, mycophenolate, or tyrosine kinase inhibitors (eg, dasatinib, erlotinib) because their effectiveness may be decreased by Omeprazole/Sodium Bicarbonate

    This may not be a complete list of all interactions that may occur. Ask your health care provider if Omeprazole/Sodium Bicarbonate may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


    How to use Omeprazole/Sodium Bicarbonate:


    Use Omeprazole/Sodium Bicarbonate as directed by your doctor. Check the label on the medicine for exact dosing instructions.


    • Take Omeprazole/Sodium Bicarbonate by mouth on an empty stomach at least 1 hour before eating.

    • Take Omeprazole/Sodium Bicarbonate with a full glass of water (8 oz/240 mL). Do not take Omeprazole/Sodium Bicarbonate with other liquids.

    • Swallow Omeprazole/Sodium Bicarbonate whole. Do not break, crush, or chew before swallowing. Do not open the capsule and sprinkle the contents on food.

    • You may take antacids while you are using Omeprazole/Sodium Bicarbonate if you are directed to do so by your doctor.

    • If you miss a dose of Omeprazole/Sodium Bicarbonate, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

    Ask your health care provider any questions you may have about how to use Omeprazole/Sodium Bicarbonate.



    Important safety information:


    • Omeprazole/Sodium Bicarbonate may cause drowsiness or dizziness. These effects may be worse if you take it with alcohol or certain medicines. Use Omeprazole/Sodium Bicarbonate with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

    • Contact your doctor if you have any signs of a bleeding ulcer, such as black, tarry stools or vomit that looks like coffee grounds, or if you experience throat pain, chest pain, severe stomach pain, or trouble swallowing.

    • Omeprazole/Sodium Bicarbonate may increase the risk of hip, wrist, and spine fractures in patients with weak bones (osteoporosis). The risk may be greater if you use Omeprazole/Sodium Bicarbonate in high doses, for longer than a year, or if you are over 50 years old. Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor. Contact your doctor if you have any questions about this information.

    • Low blood magnesium levels have been reported rarely in patients taking PPIs for at least 3 months. In most cases, this effect was seen after a year of treatment. If you will be taking Omeprazole/Sodium Bicarbonate for a long time, or if you take certain other medicines (eg, digoxin, diuretics), your doctor may perform lab tests to check for low blood magnesium levels. Seek medical attention right away if you experience symptoms of low blood magnesium levels (eg, dizziness; fast or irregular heartbeat; involuntary muscle movements; jitteriness or tremors; muscle aches, cramps, pain, spasms, or weakness; seizures).

    • Check with your doctor to see whether you should take a calcium and vitamin D supplement while you use Omeprazole/Sodium Bicarbonate.

    • Certain brands of Omeprazole/Sodium Bicarbonate may only be taken for a 14-day course once every 4 months unless your doctor tells you otherwise. Contact your doctor if you have any questions about this information.

    • Omeprazole/Sodium Bicarbonate has sodium in it. Include this when you count your daily intake of sodium.

    • Long-term use of Omeprazole/Sodium Bicarbonate with calcium or milk may cause milk-alkali syndrome. Check with your doctor before you take calcium supplements or antacids that contain calcium or drink milk while you are taking Omeprazole/Sodium Bicarbonate.

    • Both strengths of Omeprazole/Sodium Bicarbonate contain the same amount of sodium bicarbonate. Therefore, if your doctor has prescribed the 40 mg dose, do not take 2 of the 20 mg capsules to make a 40 mg dose.

    • Omeprazole/Sodium Bicarbonate may interfere with certain lab tests. Be sure your doctor and lab personnel know you are taking Omeprazole/Sodium Bicarbonate.

    • Omeprazole/Sodium Bicarbonate should be used with extreme caution in Asian patients; the risk of side effects may be increased in these patients.

    • Use Omeprazole/Sodium Bicarbonate with caution in the ELDERLY; they may be more sensitive to its effects, especially hip, wrist, and spine fractures.

    • Omeprazole/Sodium Bicarbonate should be used with extreme caution in CHILDREN younger than 18 years old; safety and effectiveness in these children have not been confirmed.

    • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Omeprazole/Sodium Bicarbonate while you are pregnant. Omeprazole/Sodium Bicarbonate is found in breast milk. Do not breast-feed while taking Omeprazole/Sodium Bicarbonate.


    Possible side effects of Omeprazole/Sodium Bicarbonate:


    All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



    Diarrhea; gas; headache; nausea; stomach pain; vomiting.



    Seek medical attention right away if any of these SEVERE side effects occur:

    Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); bone pain; chest pain; dark urine; fast, slow, or irregular heartbeat; fever, chills, or sore throat; red, swollen, blistered, or peeling skin; seizures; severe diarrhea; severe stomach pain or cramps; swelling of the hands, ankles, or feet; unusual bruising or bleeding; unusual or sudden weight increase; unusual tiredness; vision changes; yellowing of the eyes or skin.



    This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


    See also: Omeprazole/Sodium Bicarbonate side effects (in more detail)


    If OVERDOSE is suspected:


    Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; fast heartbeat; flushing; increased sweating; seizures; severe headache, drowsiness, or nausea; vomiting.


    Proper storage of Omeprazole/Sodium Bicarbonate:

    Store Omeprazole/Sodium Bicarbonate at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Omeprazole/Sodium Bicarbonate out of the reach of children and away from pets.


    General information:


    • If you have any questions about Omeprazole/Sodium Bicarbonate, please talk with your doctor, pharmacist, or other health care provider.

    • Omeprazole/Sodium Bicarbonate is to be used only by the patient for whom it is prescribed. Do not share it with other people.

    • If your symptoms do not improve or if they become worse, check with your doctor.

    • Check with your pharmacist about how to dispose of unused medicine.

    This information is a summary only. It does not contain all information about Omeprazole/Sodium Bicarbonate. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



    Issue Date: February 1, 2012

    Database Edition 12.1.1.002

    Copyright © 2012 Wolters Kluwer Health, Inc.

    More Omeprazole/Sodium Bicarbonate resources


    • Omeprazole/Sodium Bicarbonate Side Effects (in more detail)
    • Omeprazole/Sodium Bicarbonate Use in Pregnancy & Breastfeeding
    • Drug Images
    • Omeprazole/Sodium Bicarbonate Drug Interactions
    • Omeprazole/Sodium Bicarbonate Support Group
    • 15 Reviews for Omeprazole/Sodium Bicarbonate - Add your own review/rating


    Compare Omeprazole/Sodium Bicarbonate with other medications


    • Duodenal Ulcer
    • Erosive Esophagitis
    • Gastrointestinal Hemorrhage
    • GERD
    • Stomach Ulcer

    Monday, 23 May 2011

    Pregaric




    Pregaric may be available in the countries listed below.


    Ingredient matches for Pregaric



    Mecobalamin

    Mecobalamin is reported as an ingredient of Pregaric in the following countries:


    • India

    Pregabalin

    Pregabalin is reported as an ingredient of Pregaric in the following countries:


    • India

    International Drug Name Search

    Compound W




    In the US, Compound W (salicylic acid topical) is a member of the following drug classes: topical acne agents, topical keratolytics and is used to treat Acne and Warts.

    US matches:

    • Compound W

    • Compound W One-Step Wart Remover Topical

    • Compound W Plus Topical

    • Compound W Topical

    UK matches:

    • Compound W (SPC)

    Ingredient matches for Compound W



    Salicylic Acid

    Salicylic Acid is reported as an ingredient of Compound W in the following countries:


    • Ireland

    • United Kingdom

    • United States

    International Drug Name Search

    Glossary

    SPC Summary of Product Characteristics (UK)

    Click for further information on drug naming conventions and International Nonproprietary Names.

    Sunday, 22 May 2011

    Neogasol




    Neogasol may be available in the countries listed below.


    Ingredient matches for Neogasol



    Simeticone

    Simeticone is reported as an ingredient of Neogasol in the following countries:


    • Ecuador

    International Drug Name Search

    Prokain Penicillin




    Prokain Penicillin may be available in the countries listed below.


    Ingredient matches for Prokain Penicillin



    Benzylpenicillin

    Benzylpenicillin potassium (a derivative of Benzylpenicillin) is reported as an ingredient of Prokain Penicillin in the following countries:


    • Turkey

    Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Prokain Penicillin in the following countries:


    • Turkey

    International Drug Name Search

    Tuesday, 17 May 2011

    Prednison Streuli




    Prednison Streuli may be available in the countries listed below.


    Ingredient matches for Prednison Streuli



    Prednisone

    Prednisone is reported as an ingredient of Prednison Streuli in the following countries:


    • Switzerland

    International Drug Name Search

    Friday, 13 May 2011

    Panadol Antigrippine




    Panadol Antigrippine may be available in the countries listed below.


    Ingredient matches for Panadol Antigrippine



    Paracetamol

    Paracetamol is reported as an ingredient of Panadol Antigrippine in the following countries:


    • Switzerland

    Pseudoephedrine

    Pseudoephedrine hydrochloride (a derivative of Pseudoephedrine) is reported as an ingredient of Panadol Antigrippine in the following countries:


    • Switzerland

    International Drug Name Search

    Sunday, 1 May 2011

    Aequamen




    Aequamen may be available in the countries listed below.


    Ingredient matches for Aequamen



    Betahistine

    Betahistine dimesilate (a derivative of Betahistine) is reported as an ingredient of Aequamen in the following countries:


    • Germany

    International Drug Name Search

    Tuesday, 12 April 2011

    Cosudex




    Cosudex may be available in the countries listed below.


    Ingredient matches for Cosudex



    Bicalutamide

    Bicalutamide is reported as an ingredient of Cosudex in the following countries:


    • Australia

    International Drug Name Search

    Monday, 11 April 2011

    Itraconazol PCH




    Itraconazol PCH may be available in the countries listed below.


    Ingredient matches for Itraconazol PCH



    Itraconazole

    Itraconazole is reported as an ingredient of Itraconazol PCH in the following countries:


    • Netherlands

    International Drug Name Search

    Sunday, 10 April 2011

    Pantor




    Pantor may be available in the countries listed below.


    Ingredient matches for Pantor



    Pantoprazole

    Pantoprazole sodium (a derivative of Pantoprazole) is reported as an ingredient of Pantor in the following countries:


    • Bosnia & Herzegowina

    International Drug Name Search

    Paracétamol Isomed




    Paracétamol Isomed may be available in the countries listed below.


    Ingredient matches for Paracétamol Isomed



    Paracetamol

    Paracetamol is reported as an ingredient of Paracétamol Isomed in the following countries:


    • France

    International Drug Name Search

    Friday, 8 April 2011

    Vaira




    Vaira may be available in the countries listed below.


    Ingredient matches for Vaira



    Olanzapine

    Olanzapine is reported as an ingredient of Vaira in the following countries:


    • Croatia (Hrvatska)

    International Drug Name Search